Navigation Links
InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
Date:11/8/2007

LOS ALTOS, Calif., Nov. 8 /PRNewswire/ -- InteKrin Therapeutics, Inc., a privately-held clinical stage biopharmaceutical company focused on the development and commercialization of novel drugs for the treatment of diabetes and cardio-metabolic diseases, announced today that Alex M. DePaoli M.D. has joined the company as Chief Medical Officer. Dr. DePaoli will be a member of InteKrin's senior management team and will be responsible for the clinical development of the Company's pipeline of products.

"We are extremely pleased to have a seasoned world-class drug developer of Alex's caliber join the company," said Denny Lanfear, InteKrin Chief Executive. "Alex joins us as we prepare to initiate the Phase IIb study for our lead compound INT131, a non-TZD selective PPAR-gamma modulator (SPPARM) licensed from Amgen earlier this year. While at Amgen, Alex was broadly responsible for the metabolic and endocrine therapeutic area and has been closely involved with multiple novel treatment strategies. His decision to join InteKrin and direct INT131's further development is a strong endorsement of his confidence in its therapeutic potential. The addition of such a highly regarded drug developer and clinician to the team is very positive for the Company."

"I am thrilled to be joining the team at InteKrin and to have the opportunity to advance INT131 into Phase IIb in early 2008," said Dr. DePaoli. "This moiety is the result of a 10-year comprehensive scientific program at Tularik and Amgen resulting in what could be a significant clinical advancement in the treatment of Type 2 Diabetes. Insulin resistance is the key etiological feature to the onset and subsequent progression of the disease and as a true SPPARM, INT131 promises insulin sensitization benefits without the edema, fluid retention and weight gain exhibited by the TZDs."

Dr. DePaoli joins InteKrin after more than 16 years of experience in the diabetes and obesity field. He trained in Clinical and
'/>"/>

SOURCE InteKrin Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
2. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
3. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
4. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
5. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
6. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
7. Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
8. WorldHeart Appoints David Pellone Chief Financial Officer
9. Novo Nordisk Appoints New Leader of North American Business
10. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
11. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 2015 , ... Abt Associates has named Selena Ramkeesoon, a ... In her position, Ramkeesoon will help build and expand work in communications, and ... to a decade at ICF International, most recently as a vice president. During ...
(Date:7/29/2015)... ... July 29, 2015 , ... Gender minority ... Since 2012, Massachusetts law has provided legal protections against discrimination on the basis ... does not protect against discrimination based on gender identity in places open to ...
(Date:7/29/2015)... ... July 29, 2015 , ... " Core Organizer ” was featured on ... and coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the ... how this app will help anyone get organized. , Wouldn’t it be great if ...
(Date:7/29/2015)... ... July 29, 2015 , ... Join Luz Delia Gerber and Abbi Ferrin ... Well-Being begins with understanding how the body actually works. A state of mindfulness allows ... will receive tips on how to forge this new relationship with their bodies. , ...
(Date:7/29/2015)... ... July 29, 2015 , ... Ticket Down is a reliable source of ... vs. USA . , The international soccer schedule of matches played on American ... on September 8th, one of the world’s greatest teams, Brazil, will travel to North ...
Breaking Medicine News(10 mins):Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Get More Organized with the Core Organizer App 2Health News:Pampering and Empowerment Abound at Final Event in Luz Delia Gerber’s Book Unveiling 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3
... Daytime sleepiness, a common complaint of people with obstructive sleep ... a new study. Sleep apnea occurs when the airway ... in breathing that usually last a few seconds but ... The most common treatment for adults is continuous positive airway ...
... 31, 2011 Researchers at Memorial Sloan-Kettering Cancer ... University and Hybrid Silica Technologies, have received approval ... from the US Food and Drug Administration (FDA) ... targeted molecular imaging of cancer, which may be ...
... 31 (HealthDay News) -- Super Bowl fans, beware: Research ... the Green Bay Packers could be a killer, literally. ... the emotional stress that comes with watching the defeat ... appears real, a Los Angeles-based study team cautions, with ...
... to build an extra natural layer of nanoparticle-like armour has ... startlingly simple way to give drug bearing polymer vesicles (microscopic ... The Warwick researchers have been able to decorate these ... strategy in the design of vehicles for drug release, for ...
... a pathological syndrome that is usually classified into the ... Milwaukee criteria. However, this classification has some drawbacks in ... and failure to properly guide diagnosis and treatment. ... the World Journal of Gastroenterology addresses this ...
... Springer and the International Society of Cellular Oncology (ISCO) ... this year. Cellular Oncology is the official ... on the latest advances in cancer research. It was ... publishes scientific contributions from biomedical and clinical disciplines ...
Cached Medicine News:Health News:Drowsiness May Decline After Apnea Surgery 2Health News:Cancer-targeting investigational nanoparticle receives FDA IND approval for first-in-human trial 2Health News:Cancer-targeting investigational nanoparticle receives FDA IND approval for first-in-human trial 3Health News:Super Bowl Loss Really a Heart Stopper for Some Fans 2Health News:Super Bowl Loss Really a Heart Stopper for Some Fans 3Health News:Plankton inspires creation of stealth armor for slow-release microscopic drug vehicles 2Health News:Springer to publish Cellular Oncology 2
(Date:7/29/2015)... 2015 Pulmatrix, Inc., (NASDAQ: PULM ... 2015 at 10:45 am EDT. As part of ... Officer, will review Pulmatrix,s strategic plan and provide ... therapeutics based on their proprietary iSPERSE™ inhaled dry ... 6, 2015 Time:    10:45 am EDT Link:      ...
(Date:7/29/2015)...  Fifty groups representing 500,000 patients, doctors, and researchers ... the AllTrials campaign in the US. The global campaign ... to be registered and the results from it reported. ... explains: "Patients want the treatments that are best ... works. Unfortunately, we now know that around half of ...
(Date:7/29/2015)... 2015 Breckenridge Pharmaceutical, Inc. announced today ... 0.1%. The U.S. Food and Drug Administration granted final approval ... is AB rated to Astelin®, a drug marketed ... spray) is a $69 million dollar generic market ... Azelastine HCl Nasal Solution is indicated for the ...
Breaking Medicine Technology:Pulmatrix to Webcast Investor Presentation and Provide Update on Pipeline of Inhaled Therapeutics August 6th 2Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: